EMAIL THIS PAGE TO A FRIEND

Bioorganic & medicinal chemistry

Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry.


PMID 25155912

Abstract

Highly efficient drug carriers targeting hepatocyte is needed for treatment for liver diseases such as liver cirrhosis and virus infections. Galactose or N-acetylgalactosamine is known to be recognized and incorporated into the cells through asialoglycoprotein receptor (ASGPR) that is exclusively expressed on hepatocyte and hepatoma. In this study, we synthesized a galactose-modified lipid with aromatic ring with click chemistry. To make a complex with DNA, termed 'lipoplex', we prepared a binary micelle composed of cationic lipid; dioleoyltrimethylammoniumpropane (DOTAP) and galactose-modified lipid (D/Gal). We prepared lipoplex from plasmid DNA (pDNA) and D/Gal and examined the cell specificity and transfection efficiency. The lipoplex was able to interact with ASGPR immobilized on gold substrate in the quartz-crystal microbalance (QCM) sensor cell. The lipoplex induced high gene expression to HepG2 cells, a human hepatocellular carcinoma cell line, but not to A549 cells, a human alveolar adenocarcinoma cell line. The treatment with asialofetuin, which is a ligand for ASGPR and would work as a competitive inhibitor, before addition of the lipoplexes decreased the expression to HepG2 cells. These results indicate that D/Gal lipoplex was incorporated into HepG2 cells preferentially through ASGPR and the uptake was caused by galactose specific receptor. This delivery system to hepatocytes may overcome the problems for gene therapy and be used for treatment of hepatitis and hepatic cirrhosis.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

16970
1-Bromododecane, purum, ≥95.0% (GC)
C12H25Br
B65551
1-Bromododecane, 97%
C12H25Br
368113
3,5-Dihydroxybenzaldehyde, 98%
C7H6O3
C8027
Copper(II) sulfate pentahydrate, BioReagent, suitable for cell culture, ≥98%
CuO4S · 5H2O
C3036
Copper(II) sulfate pentahydrate, plant cell culture tested, ≥98%
CuO4S · 5H2O
203165
Copper(II) sulfate pentahydrate, 99.999% trace metals basis
CuO4S · 5H2O
469130
Copper(II) sulfate pentahydrate, 99.995% trace metals basis
CuO4S · 5H2O
209198
Copper(II) sulfate pentahydrate, ACS reagent, ≥98.0%
CuO4S · 5H2O
C7631
Copper(II) sulfate pentahydrate, ReagentPlus®, ≥98.0%
CuO4S · 5H2O
31293
Copper(II) sulfate pentahydrate, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99-102%
CuO4S · 5H2O
61245
Copper(II) sulfate pentahydrate, purum p.a., crystallized, ≥99.0% (RT)
CuO4S · 5H2O
12849
Copper(II) sulfate pentahydrate, puriss., suitable for, meets analytical specification of Ph. Eur., BP, USP,FCC
CuO4S · 5H2O
RES10395-B7
Cupric sulfate pentahydrate, PharmaGrade, EP, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
CuO4S · 5H2O
164992
Sodium methoxide, reagent grade, 95%, powder
CH3NaO
403067
Sodium methoxide solution, ACS reagent, 0.5 M CH3ONa in methanol (0.5N)
CH3NaO
156256
Sodium methoxide solution, 25 wt. % in methanol
CH3NaO